Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

225
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
225
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

554
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
554
Menses Phase01:18

Menses Phase

358
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
358
The Menstrual Cycle01:19

The Menstrual Cycle

1.0K
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
1.0K
Secretory Phase01:19

Secretory Phase

1000
The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
1000
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

435
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
435

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Institutional Assessment of Imposterism Among Internal Medicine Residents.

Journal of general internal medicine·2026
Same author

Combating Racism: Effects of a Longitudinal Community-Based Curriculum at the Graduate Medical Level.

Southern medical journal·2025
Same author

Effectiveness of SMS reminders to increase demand for HPV immunisation: a randomised controlled trial in Georgia.

BMJ open·2025
Same author

Hearing Patient Stories: Use of Medical Humanities on a Large-Scale, Virtual Platform to Improve Clinician Engagement.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2025
Same author

Assessing the Impact of a Virtual VA Women's Health Mini-Residency on Primary Care Provider Knowledge.

Journal of general internal medicine·2024
Same author

What/Why/When/Where/How Framework and Faculty Development Workshop to Improve the Utility of Narrative Evaluations for Assessing Internal Medicine Residents.

MedEdPORTAL : the journal of teaching and learning resources·2024
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Aug 11, 2025

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.5K

Menopause.

Andrea E Carter1, Sarah Merriam2

  • 1Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 200 Lothrop Street, MUH W923, Pittsburgh, PA 15213, USA.

The Medical Clinics of North America
|February 9, 2023
PubMed
Summary
This summary is machine-generated.

Menopause brings estrogen decline and symptoms like hot flashes. Hormone therapy effectively treats moderate-to-severe vasomotor symptoms, with nonhormonal options available for those avoiding or unable to use hormones.

Keywords:
Genitourinary syndrome of menopauseHormone therapyMenopauseVasomotor symptoms

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

1.9K

Related Experiment Videos

Last Updated: Aug 11, 2025

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.5K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

1.9K

Area of Science:

  • Reproductive Endocrinology
  • Women's Health
  • Menopause Management

Background:

  • Menopause is defined as 12 months post-final menstrual period, characterized by decreased estrogen.
  • Common symptoms include vasomotor (e.g., hot flashes) and genitourinary issues.
  • These symptoms significantly impact quality of life for many women.

Purpose of the Study:

  • To review the efficacy of hormone therapy for menopausal vasomotor symptoms.
  • To discuss alternative nonhormonal treatments for women who cannot or prefer not to use hormone therapy.
  • To provide an overview of current menopause symptom management strategies.

Main Methods:

  • Literature review of clinical guidelines and research on menopause treatments.
  • Analysis of studies comparing hormone therapy to nonhormonal interventions.
  • Synthesis of evidence regarding pharmacologic and nonpharmacologic approaches.

Main Results:

  • Hormone therapy is the most effective treatment for moderate-to-severe vasomotor symptoms.
  • It is considered first-line therapy for eligible women early in the menopausal transition.
  • Nonhormonal pharmacologic and nonpharmacologic options offer alternatives for specific patient groups.

Conclusions:

  • Hormone therapy remains a primary treatment for vasomotor symptoms in menopause.
  • A range of effective nonhormonal options exist for women with contraindications or preferences against hormone use.
  • Personalized treatment plans are essential for managing menopause-related symptoms effectively.